30 closest matches · ranked by relevance
Solid Tumor, Adult
Primary: Likelihood of Accruing Participants: Feasibility of Enrollment — 27; 24 Participants
Cancer
Primary: Interviews — 20 Interviews
Breast Cancer · Colorectal Cancer
Primary: Proportion of Complex Cancer Survivors Meeting Quality of Care Guidelines for Chronic Conditions and Follow-up Cancer Surveillance
Lung Cancer · Tobacco Use Disorder · Breast Cancer
Primary: Feasibility of a Smoking Cessation Intervention Among Cancer Patients — 55; 33 Participants
Adult Solid Neoplasm · Lymphoma
Primary: Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology…
Infectious Disease · Cancer · Coronavirus Infection
Primary: Percentage of Patients at Each Sample Timepoint With a Positive Detection of Immunoglobulin G (IgG) Specific Antibodies to SARS-CoV-2 (Spike-protein). — 34.9; 38.3…
Neoplasms
Primary: Mean Changes From Baseline in Self-esteem Scores on the Rosenberg Self-esteem Scale (RSES) to Two-, Six-, and Eight Weeks Post Baseline — 23.4; 23.5; 23.7; 24.2 score on…
Smoking, Cigarette
Primary: Smoking 7-Day Point Prevalence at 12 Weeks — 2; 2; 3 Participants
Advanced Solid Tumor Diseases
Primary: Participant Meaning Making Scores Using the Life Attitude Profile-Revised (LAP-R) — 37.07; 38.28; 36.80; 42.22 scores on a scale
Cancer
Primary: Number of Study Participants Who Have Completed a Palliative Care Visit Within 3 Months of Enrollment — 22; 130 participants
Gynecologic Cancer · Colorectal Cancer · Lung Cancer
Primary: Difference in Health Insurance Knowledge Between Historical Control Arm and I Can PIC Arm — 72.45; 77.02 score on a scale — p=0.15
Cancer Metastatic to Brain · Brain Metastases, Adult
Primary: Assess the Need for Adaptations to the CALM Intervention as Measured by the Applicability of the 4 CALM Domains — 3.2; 4.0; 4.0; 3.5 score on a scale
Cancer · Anxiety · Compassion
Primary: Anxiety Subscale of the Hospital Anxiety and Depression Scale (HADS) — 7; 7 score on a scale — p=0.473
Cancer, Lung · Cancer, Head and Neck
Primary: Symptoms of Depression-Patients — 15.3; 13.2 score on a scale — p=0.0057
Cancer
Primary: Summed Symptom Severity — 23.2; 19.9 units on a scale — p=0.030
Breast Cancer · Colorectal Cancer · Kidney Cancer
Primary: Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation — 199; 93; 141; 80 Participants
COVID-19
Primary: Number and Severity of Confirmed COVID-19 Infections Among Cancer Centre Staff and Patients at 12 Months — 55; 36 Participants
Mood · Cancer Brain
Primary: Recruitment for CALM — 14; 14; 12 Participants
Cancer
Primary: Provider to Patient Communication Score — 1.0423; 1.0723 score on a scale
Lymphoma · Digestive System Diseases · Ovarian Diseases
Primary: Number of Participant Deaths — 56 Participants
Cognitive Dysfunction
Primary: MAAT-G Feasibility Completion Rate — 10 Participants
Smoking Cessation
Primary: Number of Participants With Biochemically Verified 7-day Point Prevalence Tobacco Abstinence at 6 Months — 29; 51 Participants
Adolescent and Young Adult Cancer Patient
Primary: Treatment Acceptability Questionnaire — 6.02 score on a scale
Pain
Primary: Primary Reduction of Pain — 2.55; 1.40 units on a scale from 0 to 10
Survivorship · Cancer · Symptoms and Signs
Primary: Number of Participants Who Logged Data at Least Three Times in the POSTHOC App — 12; 1 Participants
Cancer
Primary: Symptom Severity Index- Comparison of Two Groups Created by First Randomization — 26.28; 26.55; 12.02; 11.19 units on a scale — p=.81
Neoplasms
Primary: Patient-Reported Outcomes Measurement System Scale, a Scale Developed by the National Institute of Health to Assess Outcomes Across Different Trials. — 8.90; 12.26…
Cancer
Primary: Number of Participants With Positive Viral Infection — 19; 197; 71; 34 Participants
Lung Cancer
Primary: Feasibility of Using CH for Full-scale Future Research — 15; 6; 5 participants
Colon Cancer · Rectal Cancer
Primary: Patient Retention and Engagement With the MyChemoCare Application — 15; 12 Participants